Strategic Partnerships Microdose has a track record of active partnerships with Lifespan Research Institute, Catalent, Concordia, and Enosis Therapeutics, indicating openness to collaboration with pharma, research, and event-focused ecosystems that could be leveraged for joint ventures, sponsorships, or content distribution deals.

Industry Thought Leadership As a leading source of news and insights in the psychedelic medicine space with a broad media presence, Microdose is a strong channel for sponsored content, webinars, and targeted ad programs to reach professionals and potential patients in this niche market.

Clinical Trial Ecosystem Active initiatives in DMT stroke research and feasibility studies with MDMA therapy suggest opportunities to offer trial recruitment services, investigator connections, or data/education platforms that align with pharma and biotech sponsors seeking clinical outcomes visibility.

Global Expansion Footprint Past acquisition and US market entry momentum, plus plans to scale clinics and practitioner training, point to potential for cross-border sponsorships, regional media packages, and localized content or events that target clinics, providers, and investors in multiple regions.

Revenue Growth Signals With reported revenue in the low to mid seven figures and a diverse tech stack for advertising, analytics, and outreach, there are opportunities to upsell premium analytics, audience segmentation, and direct advertising packages to brands seeking visibility in psychedelics consumer and professional audiences.